Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A literature review shows promising signs that teenagers, like adults, can benefit from methadone, buprenorphine and naltrexone.
A long-term study sought to determine which factors help predict low adherence among young people with the virus.
Untreated sexually transmitted infections can lead to pelvic inflammatory disease, which can complicate women’s ability to get pregnant.
The study also projected that PrEP use among adult gay and bi men would result in a considerable reduction in HIV among adolescents.
Porchia shares the complexities of dating, disclosure, intimacy, and relationships as a young woman living with HIV
A recent study analyzed half a million visits to children hospitals by those 14 to 18 years old.
As the current number of Americans on PrEP hits an estimated 180,000, scant numbers of teenagers have ever taken Truvada as HIV prevention.
A recent online survey found a high level of awareness of PrEP.
This is according to a survey of parents and adolescents at a state fair in Minnesota.
This finding is from a long-term study of risky behaviors among a largely African-American group of young people in Flint, Michigan.
A new study identifies areas where the system can do better.
A look at a group of 13- to 24-year-olds on antiretrovirals found one in six episodically had a significant viral load and an STI.
A recent study found that the antiretroviral-containing ring was safe and that the girls in the trial used it well.
The Adolescent Medicine Trials Network of HIV/AIDS Interventions launched two such programs in recent years.
Although Truvada as PrEP is not approved for those under 18, it may be prescribed off-label—but many doctors are wary.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.